Macrophage Therapy for Acute Liver Injury (MAIL): a Phase 1 Randomised, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Activity of Allogeneic Alternatively Activated Macrophages in Patients with Paracetamol-induced Acute Liver Injury

Data Availability

Results will be disseminated by peer-reviewed publication, conferences, and linked on isrctn.com. Publication content will follow the CONSORT-DEFINE reporting guidance extension for dose-finding studies. Ownership of data arising from this study resides with the study team and their respective employers. The study team will follow the International Committee of Medical Journal Editors guidelines on authorship. Requests for data access should be sent to the corresponding author.